Phosphatidylinositol 3-Kinase γ is required for the development of experimental cerebral malaria

Norinne Lacerda-Queiroz1, Fatima Brant1, David Henrique Rodrigues1

  • 1Laboratory of Immunopharmacology/Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.

Plos One
|March 17, 2015
PubMed

Insights

Phosphatidylinositol 3-kinase γ (PI3Kγ) plays a key role in experimental cerebral malaria (ECM) pathogenesis. Inhibiting PI3Kγ in mice improved survival and reduced neuroinflammation, suggesting PI3Kγ as a therapeutic target for ECM.

Area of Science:

  • Immunology
  • Neuroscience
  • Pathology

Background:

  • Experimental cerebral malaria (ECM) involves significant neuroinflammation, leukocyte infiltration, and blood-brain barrier disruption.
  • Phosphatidylinositol 3-kinase γ (PI3Kγ) is a crucial signaling molecule in various cellular processes, including immune responses.

Purpose of the Study:

  • To investigate the role of PI3Kγ in the pathogenesis of experimental cerebral malaria (ECM) caused by Plasmodium berghei ANKA (PbA) infection.
  • To evaluate the therapeutic potential of targeting PI3Kγ in ECM.

Main Methods:

  • Utilized PI3Kγ-deficient mice (PI3Kγ-/-) and a specific PI3Kγ inhibitor (AS605240).
  • Assessed survival rates, parasitemia, and performed histopathological analyses of brain tissue.
  • Quantified microglial activation, T cell cytotoxicity, CD8+ T cell populations, and key signaling molecules (phospho-IkB-α).

Main Results:

  • PI3Kγ-/- mice exhibited significantly increased survival rates compared to wild-type mice, despite similar parasite loads.
  • Histological examination revealed reduced hemorrhage, leukocyte accumulation, and vascular obstruction in the brains of PI3Kγ-/- mice.
  • PI3Kγ deficiency led to decreased microglial activation, T cell cytotoxicity (Granzyme B), and reduced CD8+ T cell infiltration and CD44 expression in the brain.

Conclusions:

  • PI3Kγ is critically involved in the neuroinflammatory processes and pathogenesis of experimental cerebral malaria.
  • Targeting PI3Kγ demonstrates therapeutic potential, as inhibition significantly improved survival and reduced disease severity in a murine model of ECM.